Schering gets US OK for Betaseron in early stage MS
Last Updated: 2006-10-23 16:00:43 -0400 (Reuters Health) | | | FRANKFURT (Reuters) - German drugmaker Schering has received approval from U.S. regulators for the use of its Betaseron drug for early stage multiple sclerosis, it said on Monday. | MS News is brought to you by the Consortium of MS Centers as part of the eMS-Health Project funded by an unrestricted grant from Teva Neuroscience.
Copyright © 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world. |
|
CMSC Online 
